These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6336421)

  • 1. Bulk-heparinized catheters do not generate fibrinopeptide A in an ex-vivo test in dogs.
    Eloy R; Pusinéri C; Baguet J; Paul J; Serafini S
    Life Support Syst; 1983; 1 Suppl 1():247-50. PubMed ID: 6336421
    [No Abstract]   [Full Text] [Related]  

  • 2. Requirements for thromboresistance of surface-heparinized materials.
    Olsson P; Larm O; Larsson R; Lins LE; Nilsson E; Swedenborg J
    Ann N Y Acad Sci; 1983; 416():525-37. PubMed ID: 6145383
    [No Abstract]   [Full Text] [Related]  

  • 3. Thromboresistance of bulk heparinized catheters in human.
    Eloy R; Belleville J; Paul J; Pusinéri C; Baguet J; Rissoan MC; Cathignol D; Ffrench P; Ville D; Tartullier M
    Thromb Res; 1987 Feb; 45(3):223-33. PubMed ID: 2958956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane B2 and fibrinopeptide A levels in platelet consumption and thrombosis.
    Davies GC; Mowschenson PM; Salzman EW
    Surg Forum; 1978; 29():471-2. PubMed ID: 401227
    [No Abstract]   [Full Text] [Related]  

  • 5. The action of thrombin on modified fibrinogen.
    Osbahr AJ
    Thromb Haemost; 1983 Jun; 49(3):208-13. PubMed ID: 6410533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-dependent fibrinopeptide A accessibility to thrombin.
    Geer CB; Rus IA; Lord ST; Schoenfisch MH
    Acta Biomater; 2007 Sep; 3(5):663-8. PubMed ID: 17540627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation.
    Meinhardt JP; Annich GM; Miskulin J; Kawai T; Ashton BA; Bartlett RH
    ASAIO J; 2003; 49(4):395-400. PubMed ID: 12918580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinopeptide A behaviour in chronic active hepatitis patients.
    Violi F; Alessandri C; Ferro D; Gallina G; Iuliano L; Balsano F
    Haematologica; 1984; 69(6):655-60. PubMed ID: 6441741
    [No Abstract]   [Full Text] [Related]  

  • 9. Bound and circulating heparin in an ECMO system thrombogenicity versus functionality.
    Roohk HV; Calabrese D; Sanematsu L; Castillo G; Cottonaro CN
    Trans Am Soc Artif Intern Organs; 1984; 30():639-43. PubMed ID: 6533950
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin-coated angiographic catheters: an in vivo comparison of three coating methods with different heparin release profiles.
    Lee KH; Han JK; Byun Y; Moon HT; Yoon CJ; Kim SJ; Choi BI
    Cardiovasc Intervent Radiol; 2004; 27(5):507-11. PubMed ID: 15383856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discard volumes necessary for clinically useful coagulation studies from heparinized Hickman catheters.
    Mayo DJ; Dimond EP; Kramer W; Horne MK
    Oncol Nurs Forum; 1996 May; 23(4):671-5. PubMed ID: 8735325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of fibrinopeptide A in the evaluation of heparin activity and fibrin formation during hemodialysis.
    Wilhelmsson S; Asaba H; Gunnarsson B; Kudryk B; Robinson D; Bergström J
    Clin Nephrol; 1981 May; 15(5):252-8. PubMed ID: 7249422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
    Rooney MM; Mullin JL; Lord ST
    Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin polymerization studied by static and dynamic light-scattering as a function of fibrinopeptide A release.
    Wiltzius P; Dietler G; Känzig W; Häberli A; Straub PW
    Biopolymers; 1982 Nov; 21(11):2205-23. PubMed ID: 7171733
    [No Abstract]   [Full Text] [Related]  

  • 15. The measurement of plasma fibrinopeptide A in breast cancer patients.
    Sagripanti A; Carpi A; Ferdeghini M; Pinori E; Nicolini A
    Rays; 1987; 12(2):65-9, 107-9. PubMed ID: 3444915
    [No Abstract]   [Full Text] [Related]  

  • 16. A fibrin clot stops low density lipoprotein apheresis.
    Bordin P; Petrucco A; Fiotti N; Giacomello R; Cattin L
    ASAIO J; 1995; 41(2):234-5. PubMed ID: 7640435
    [No Abstract]   [Full Text] [Related]  

  • 17. Surface and blood-contacting properties of alkylsiloxane monolayers supported on silicone rubber.
    Silver JH; Hergenrother RW; Lin JC; Lim F; Lin HB; Okada T; Chaudhury MK; Cooper SL
    J Biomed Mater Res; 1995 Apr; 29(4):535-48. PubMed ID: 7622539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombogenic heparinized polyacrylonitrile copolymer.
    Miyama H; Fujii N; Kuwano A; Nagaoka S; Mori Y; Noishiki Y
    J Biomed Mater Res; 1986 Sep; 20(7):895-901. PubMed ID: 3760006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of blood compatible surfaces. Part I. Dynamic tube test applied to heparinized surfaces.
    Dudley B; Williams JL; Able K; Muller B
    Trans Am Soc Artif Intern Organs; 1976; 22():538-44. PubMed ID: 951872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinopeptide A as a measure of coagulation activity induced by surgery. An experimental study in dogs.
    Medén-Britth G; Rådegran K
    Thromb Res; 1980 May 1-15; 18(3-4):333-41. PubMed ID: 7414534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.